{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69423-946",
      "generic_name": "GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE",
      "labeler_name": "The Procter & Gamble Manufacturing Company",
      "brand_name": "Vicks DayQuil Kids Cold Cough plus Mucus",
      "brand_name_suffix": "Cold Cough plus Mucus",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "10 mg/15mL"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "5 mg/15mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "100 mg/15mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69423-946-08",
          "description": "236 mL in 1 BOTTLE, PLASTIC (69423-946-08)",
          "marketing_start_date": "20210708",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "LIQUID",
      "spl_id": "5d19fa7b-cb9b-b92b-e063-6394a90ae2e6",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20210708",
      "product_id": "69423-946_5d19fa7b-cb9b-b92b-e063-6394a90ae2e6",
      "application_number": "M012",
      "brand_name_base": "Vicks DayQuil Kids",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}